{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T09:08:01Z","timestamp":1723280881256},"reference-count":33,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.3892\/ol.2017.6416","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T03:46:43Z","timestamp":1497844003000},"page":"2081-2088","source":"Crossref","is-referenced-by-count":10,"title":["Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy"],"prefix":"10.3892","volume":"14","author":[{"given":"Shuwen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxing","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renju","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,6,19]]},"reference":[{"key":"key20180108115057_b1-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1741-7015-11-13","article-title":"Recent advances in the diagnosis and treatment of bladder cancer","volume":"11","author":"Cheung","year":"2013","journal-title":"BMC Med"},{"key":"key20180108115057_b2-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"key20180108115057_b3-ol-0-0-6416","first-page":"69","article-title":"Molecular targeting and gene delivery in bladder cancer therapy","volume":"14","author":"Voutsinas","year":"2009","journal-title":"J Buon"},{"key":"key20180108115057_b4-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"key":"key20180108115057_b5-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0305-7372(76)80019-9","article-title":"Mitomycin C: A review","volume":"3","author":"Crooke","year":"1976","journal-title":"Cancer Treat Rev"},{"key":"key20180108115057_b6-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00001813-199010000-00002","article-title":"Mitomycin C: Mechanism of action, usefulness and limitations","volume":"1","author":"Verweij","year":"1990","journal-title":"Anticancer Drugs"},{"key":"key20180108115057_b7-ol-0-0-6416","first-page":"890","article-title":"Hydroxycamptothecin promotes the apoptosis of prostate cancer cell line PC-3","volume":"13","author":"Wu","year":"2007","journal-title":"Zhonghua Nan KeXue"},{"key":"key20180108115057_b8-ol-0-0-6416","first-page":"301","article-title":"10-Hydroxycamptothecin induces apoptosis in human T24 urinary bladder cancer cells","volume":"78","author":"Fan","year":"1998","journal-title":"Zhonghua Yi XueZaZhi"},{"key":"key20180108115057_b9-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb07020.x","article-title":"Mechanism of action of camptothecin","volume":"922","author":"Liu","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"key20180108115057_b10-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key20180108115057_b11-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MOU.0b013e32830b86e3","article-title":"Gene therapy in bladder cancer","volume":"18","author":"Bochner","year":"2008","journal-title":"Curr Opin Urol"},{"key":"key20180108115057_b12-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/109153601300177547","article-title":"Gene therapy for bladder cancer using adenoviral vector","volume":"5","author":"Wada","year":"2001","journal-title":"Mol Urol"},{"key":"key20180108115057_b13-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.gt.3301851","article-title":"Adenovirus-mediated gene therapy for bladder cancer: Efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivo","volume":"10","author":"Chester","year":"2003","journal-title":"Gene Ther"},{"key":"key20180108115057_b14-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/156652312800099599","article-title":"Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice","volume":"12","author":"Wang","year":"2012","journal-title":"Curr Gene Ther"},{"key":"key20180108115057_b15-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.urolonc.2008.02.002","article-title":"Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector","volume":"28","author":"Wang","year":"2010","journal-title":"Urol Oncol"},{"key":"key20180108115057_b16-ol-0-0-6416","first-page":"1065","article-title":"Antitumor effects of bladder cancer-specific adenovirus carrying E1A-andro gen receptor in bladder","volume":"19","author":"Zhai","year":"2012","journal-title":"cancer"},{"key":"key20180108115057_b17-ol-0-0-6416","first-page":"82","article-title":"Combination effect of oncolytic adenovirotherapy and TRAIL gene therapy in syngeneic murine breast cancer models","volume":"13","author":"Guo","year":"2006","journal-title":"Cancer GeneTher"},{"key":"key20180108115057_b18-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.cgt.7701067","article-title":"Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo","volume":"14","author":"Alonso","year":"2007","journal-title":"Cancer Gene Ther"},{"key":"key20180108115057_b19-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.11549","article-title":"Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice","volume":"108","author":"Zhou","year":"2004","journal-title":"Int J Cancer"},{"key":"key20180108115057_b20-ol-0-0-6416","first-page":"1083","article-title":"Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene","volume":"13","author":"S\u00e1nchez-Prieto","year":"1996","journal-title":"Oncogene"},{"key":"key20180108115057_b21-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/sj.cgt.7700909","article-title":"Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: Sensitization to cisplatin and doxorubicin","volume":"13","author":"Ganjavi","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"key20180108115057_b22-ol-0-0-6416","first-page":"2017","article-title":"Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism","volume":"3","author":"Brader","year":"1997","journal-title":"Clin Cancer Res"},{"key":"key20180108115057_b23-ol-0-0-6416","first-page":"250","article-title":"E1A-mediated paclitaxel sensitization in HER-2\/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway","volume":"6","author":"Ueno","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20180108115057_b24-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1128\/MCB.23.19.6836-6848.2003","article-title":"Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis","volume":"23","author":"Liao","year":"2003","journal-title":"Mol Cell Biol"},{"key":"key20180108115057_b25-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1158\/0008-5472.CAN-04-1533","article-title":"A new role of protein phosphatase 2a in adenoviral E1A protein-mediated sensitization to anticancer drug-induced apoptosis in human breast cancer cells","volume":"64","author":"Liao","year":"2004","journal-title":"Cancer Res"},{"key":"key20180108115057_b26-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1101\/gad.12.15.2434","article-title":"E1A signaling to p53 involves the p19(ARF) tumor suppressor","volume":"12","author":"de Stanchina","year":"1998","journal-title":"Genes Dev"},{"key":"key20180108115057_b27-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/35041112","article-title":"Primary cells suppress oncogene-dependent apoptosis","volume":"2","author":"Duelli","year":"2000","journal-title":"Nat Cell Biol"},{"key":"key20180108115057_b28-ol-0-0-6416","doi-asserted-by":"crossref","unstructured":"McCurrachMEConnorTMKnudsonCMKorsmeyerSJLoweSWbax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosisProc Natl Acad Sci USA9423452349199710.1073\/pnas.94.6.23459122197","DOI":"10.1073\/pnas.94.6.2345"},{"key":"key20180108115057_b29-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.1158\/0008-5472.CAN-11-0295","article-title":"FOXO3a dependent mechanism of E1A-Induced chemosensitization","volume":"71","author":"Su","year":"2011","journal-title":"Cancer Res"},{"key":"key20180108115057_b30-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0248-4900(97)86892-X","article-title":"Mitomycin C induced apoptosis: influence of cell cycle phase","volume":"88","author":"Olivier","year":"1996","journal-title":"Biology of the Cell"},{"key":"key20180108115057_b31-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tiv.2010.11.009","article-title":"Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo","volume":"25","author":"Hu","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"key20180108115057_b32-ol-0-0-6416","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1089\/10430340152710568","article-title":"Connexin 26 gene therapy of human bladder cancer: Induction of growth suppression, apoptosis, and synergy with Cisplatin","volume":"12","author":"Tanaka","year":"2001","journal-title":"Hum Gene Ther"},{"key":"key20180108115057_b33-ol-0-0-6416","first-page":"6428","article-title":"A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin","volume":"61","author":"Li","year":"2001","journal-title":"Cancer Res"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T03:45:57Z","timestamp":1569469557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.6416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,19]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,6,19]]},"published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.3892\/ol.2017.6416"],"URL":"https:\/\/doi.org\/10.3892\/ol.2017.6416","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,19]]}}}